Cargando…
Current Understanding of Pressure Natriuresis
Pressure natriuresis refers to the concept that increased renal perfusion pressure leads to a decrease in tubular reabsorption of sodium and an increased sodium excretion. The set point of blood pressure is the point at which pressure natriuresis and extracellular fluid volume are in equilibrium. Th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Electrolyte Metabolism
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715224/ https://www.ncbi.nlm.nih.gov/pubmed/35003284 http://dx.doi.org/10.5049/EBP.2021.19.2.38 |
_version_ | 1784624089346867200 |
---|---|
author | Baek, Eun Ji Kim, Sejoong |
author_facet | Baek, Eun Ji Kim, Sejoong |
author_sort | Baek, Eun Ji |
collection | PubMed |
description | Pressure natriuresis refers to the concept that increased renal perfusion pressure leads to a decrease in tubular reabsorption of sodium and an increased sodium excretion. The set point of blood pressure is the point at which pressure natriuresis and extracellular fluid volume are in equilibrium. The term "abnormal pressure natriuresis" usually refers to the expected abnormal effect of a certain level of blood pressure on sodium excretion. Factors that cause abnormal pressure natriuresis are known. Sympathetic nerve system, genetic factors, and dietary factors may affect an increase in renal perfusion pressure. An increase in renal perfusion pressure increases renal interstitial hydrostatic pressure (RIHP). Increased RIHP affects tubular reabsorption through alterations in tight junctional permeability to sodium in proximal tubules, redistribution of apical sodium transporters, and/or release of renal autacoids. Renal autocoids such as nitric oxide, prostaglandin E2, kinins, and angiotensin II may also regulate pressure natriuresis by acting directly on renal tubule sodium transport. In addition, inflammation and reactive oxygen species may mediate pressure natriuresis. Recently, the use of new drugs associated with pressure natriuretic mechanisms, such as angiotensin receptor neprilysin inhibitor and sodium glucose co-transporter 2 inhibitors, has been consistently demonstrated to reduce mortality and hypertension-related complications. Therefore, the understanding of pressure natriuresis is gaining attention as an antihypertensive strategy. In this review, we provide a basic overview of pressure natriuresis to the target audience of nephrologists. |
format | Online Article Text |
id | pubmed-8715224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Korean Society of Electrolyte Metabolism |
record_format | MEDLINE/PubMed |
spelling | pubmed-87152242022-01-07 Current Understanding of Pressure Natriuresis Baek, Eun Ji Kim, Sejoong Electrolyte Blood Press Review Article Pressure natriuresis refers to the concept that increased renal perfusion pressure leads to a decrease in tubular reabsorption of sodium and an increased sodium excretion. The set point of blood pressure is the point at which pressure natriuresis and extracellular fluid volume are in equilibrium. The term "abnormal pressure natriuresis" usually refers to the expected abnormal effect of a certain level of blood pressure on sodium excretion. Factors that cause abnormal pressure natriuresis are known. Sympathetic nerve system, genetic factors, and dietary factors may affect an increase in renal perfusion pressure. An increase in renal perfusion pressure increases renal interstitial hydrostatic pressure (RIHP). Increased RIHP affects tubular reabsorption through alterations in tight junctional permeability to sodium in proximal tubules, redistribution of apical sodium transporters, and/or release of renal autacoids. Renal autocoids such as nitric oxide, prostaglandin E2, kinins, and angiotensin II may also regulate pressure natriuresis by acting directly on renal tubule sodium transport. In addition, inflammation and reactive oxygen species may mediate pressure natriuresis. Recently, the use of new drugs associated with pressure natriuretic mechanisms, such as angiotensin receptor neprilysin inhibitor and sodium glucose co-transporter 2 inhibitors, has been consistently demonstrated to reduce mortality and hypertension-related complications. Therefore, the understanding of pressure natriuresis is gaining attention as an antihypertensive strategy. In this review, we provide a basic overview of pressure natriuresis to the target audience of nephrologists. The Korean Society of Electrolyte Metabolism 2021-12 2021-12-23 /pmc/articles/PMC8715224/ /pubmed/35003284 http://dx.doi.org/10.5049/EBP.2021.19.2.38 Text en Copyright © 2021 Korean Society for Electrolyte and Blood Pressure Research https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Article Baek, Eun Ji Kim, Sejoong Current Understanding of Pressure Natriuresis |
title | Current Understanding of Pressure Natriuresis |
title_full | Current Understanding of Pressure Natriuresis |
title_fullStr | Current Understanding of Pressure Natriuresis |
title_full_unstemmed | Current Understanding of Pressure Natriuresis |
title_short | Current Understanding of Pressure Natriuresis |
title_sort | current understanding of pressure natriuresis |
topic | Review Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8715224/ https://www.ncbi.nlm.nih.gov/pubmed/35003284 http://dx.doi.org/10.5049/EBP.2021.19.2.38 |
work_keys_str_mv | AT baekeunji currentunderstandingofpressurenatriuresis AT kimsejoong currentunderstandingofpressurenatriuresis |